1. 3108 Treatment Patterns and Survival among ALK+ Non-Small Cell Lung Cancer (NSCLC) Patients: A Chart Review Study. (September 2015) Authors: Park, K.; Cadranel, J.; Arrieta, O.; Pless, M.; Bendaly, E.; Patel, D.; Sasane, M.; Nosal, A.; Guerin, A.; Kageleiry, A.; Stein, K.; Marinsek, N.; Zhang, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. (11th November 2014) Authors: Kimball, A.B.; Jemec, G.B.E.; Yang, M.; Kageleiry, A.; Signorovitch, J.E.; Okun, M.M.; Gu, Y.; Wang, K.; Mulani, P.; Sundaram, M. Journal: British journal of dermatology Issue: Volume 171:Number 6(2014:Dec.) Page Start: 1434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. (1st December 2014) Authors: Kimball, A.B.; Jemec, G.B.E.; Yang, M.; Kageleiry, A.; Signorovitch, J.E.; Okun, M.M.; Gu, Y.; Wang, K.; Mulani, P.; Sundaram, M. Journal: British journal of dermatology Issue: Volume 171:Number 6(2014:Dec.) Page Start: 1434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0123 Clinical Outcomes Associated with Switching or Discontinuation of Anti-TNF Inhibitors for Non-Medical Reasons. (9th June 2015) Authors: Lebwohl, M.; Skup, M.; Yang, H.; Faust, E.; Kageleiry, A.; Chao, J.; Wolf, D. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗